These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 18065174

  • 1. Determination of intraliposomal pH and its effect on membrane partitioning and passive loading of a hydrophobic camptothecin, DB-67.
    Joguparthi V, Feng S, Anderson BD.
    Int J Pharm; 2008 Mar 20; 352(1-2):17-28. PubMed ID: 18065174
    [Abstract] [Full Text] [Related]

  • 2. Liposome transport of hydrophobic drugs: gel phase lipid bilayer permeability and partitioning of the lactone form of a hydrophobic camptothecin, DB-67.
    Joguparthi V, Xiang TX, Anderson BD.
    J Pharm Sci; 2008 Jan 20; 97(1):400-20. PubMed ID: 17879989
    [Abstract] [Full Text] [Related]

  • 3. Liposomal delivery of hydrophobic weak acids: enhancement of drug retention using a high intraliposomal pH.
    Joguparthi V, Anderson BD.
    J Pharm Sci; 2008 Jan 20; 97(1):433-54. PubMed ID: 17918731
    [Abstract] [Full Text] [Related]

  • 4. Enhanced active liposomal loading of a poorly soluble ionizable drug using supersaturated drug solutions.
    Modi S, Xiang TX, Anderson BD.
    J Control Release; 2012 Sep 10; 162(2):330-9. PubMed ID: 22800581
    [Abstract] [Full Text] [Related]

  • 5. Molecular dynamics simulations and experimental studies of binding and mobility of 7-tert-butyldimethylsilyl-10-hydroxycamptothecin and its 20(S)-4-aminobutyrate ester in DMPC membranes.
    Xiang TX, Jiang ZQ, Song L, Anderson BD.
    Mol Pharm; 2006 Sep 10; 3(5):589-600. PubMed ID: 17009858
    [Abstract] [Full Text] [Related]

  • 6. Effect of cyclodextrin complexation on the liposome permeability of a model hydrophobic weak Acid.
    Joguparthi V, Anderson BD.
    Pharm Res; 2008 Nov 10; 25(11):2505-15. PubMed ID: 18642063
    [Abstract] [Full Text] [Related]

  • 7. The highly lipophilic DNA topoisomerase I inhibitor DB-67 displays elevated lactone levels in human blood and potent anticancer activity.
    Bom D, Curran DP, Zhang J, Zimmer SG, Bevins R, Kruszewski S, Howe JN, Bingcang A, Latus LJ, Burke TG.
    J Control Release; 2001 Jul 06; 74(1-3):325-33. PubMed ID: 11489514
    [Abstract] [Full Text] [Related]

  • 8. pH-dependent association of SN-38 with lipid bilayers of a novel liposomal formulation.
    Peikov V, Ugwu S, Parmar M, Zhang A, Ahmad I.
    Int J Pharm; 2005 Aug 11; 299(1-2):92-9. PubMed ID: 15996839
    [Abstract] [Full Text] [Related]

  • 9. Role of copper gluconate/triethanolamine in irinotecan encapsulation inside the liposomes.
    Dicko A, Tardi P, Xie X, Mayer L.
    Int J Pharm; 2007 Jun 07; 337(1-2):219-28. PubMed ID: 17270372
    [Abstract] [Full Text] [Related]

  • 10. Copper ion-mediated liposomal encapsulation of mitoxantrone: the role of anions in drug loading, retention and release.
    Li C, Cui J, Li Y, Wang C, Li Y, Zhang L, Zhang L, Guo W, Wang J, Zhang H, Hao Y, Wang Y.
    Eur J Pharm Sci; 2008 Aug 07; 34(4-5):333-44. PubMed ID: 18573336
    [Abstract] [Full Text] [Related]

  • 11. Coencapsulation of irinotecan and floxuridine into low cholesterol-containing liposomes that coordinate drug release in vivo.
    Tardi PG, Gallagher RC, Johnstone S, Harasym N, Webb M, Bally MB, Mayer LD.
    Biochim Biophys Acta; 2007 Mar 07; 1768(3):678-87. PubMed ID: 17208196
    [Abstract] [Full Text] [Related]

  • 12. A versatile prodrug approach for liposomal core-loading of water-insoluble camptothecin anticancer drugs.
    Liu X, Lynn BC, Zhang J, Song L, Bom D, Du W, Curran DP, Burke TG.
    J Am Chem Soc; 2002 Jul 03; 124(26):7650-1. PubMed ID: 12083906
    [Abstract] [Full Text] [Related]

  • 13. Lipid membrane with low proton permeability.
    Biloti DN, Santana MH, Pessine FB.
    Biochim Biophys Acta; 2003 Apr 01; 1611(1-2):1-4. PubMed ID: 12659939
    [Abstract] [Full Text] [Related]

  • 14. Novel camptothecin analogue (gimatecan)-containing liposomes prepared by the ethanol injection method.
    Stano P, Bufali S, Pisano C, Bucci F, Barbarino M, Santaniello M, Carminati P, Luisi PL.
    J Liposome Res; 2004 Apr 01; 14(1-2):87-109. PubMed ID: 15461935
    [Abstract] [Full Text] [Related]

  • 15. Transition metal-mediated liposomal encapsulation of irinotecan (CPT-11) stabilizes the drug in the therapeutically active lactone conformation.
    Ramsay E, Alnajim J, Anantha M, Taggar A, Thomas A, Edwards K, Karlsson G, Webb M, Bally M.
    Pharm Res; 2006 Dec 01; 23(12):2799-808. PubMed ID: 17063397
    [Abstract] [Full Text] [Related]

  • 16. Determination of key parameters for a mechanism-based model to predict Doxorubicin release from actively loaded liposomes.
    Csuhai E, Kangarlou S, Xiang TX, Ponta A, Bummer P, Choi D, Anderson BD.
    J Pharm Sci; 2015 Mar 01; 104(3):1087-98. PubMed ID: 25561354
    [Abstract] [Full Text] [Related]

  • 17. Influence of intravesicular pH drift and membrane binding on the liposomal release of a model amine-containing permeant.
    Tejwani RW, Anderson BD.
    J Pharm Sci; 2008 Jan 01; 97(1):381-99. PubMed ID: 17694543
    [Abstract] [Full Text] [Related]

  • 18. Polymeric micelles of ammonium palmitoyl glycol chitosan and solubilization of camptothecin.
    Ranjha NM.
    PDA J Pharm Sci Technol; 2009 Jan 01; 63(1):81-7. PubMed ID: 19455944
    [Abstract] [Full Text] [Related]

  • 19. The comparison of biophysical properties of DB-67 and its ester DB-67-4ABTFA determined by fluorescence spectroscopy methods.
    Kruszewski S, Ziomkowska B, Cyrankiewicz M, Wybranowski T.
    Biosystems; 2008 Dec 01; 94(3):270-5. PubMed ID: 18718502
    [Abstract] [Full Text] [Related]

  • 20. Artificial lipids stabilized camptothecin incorporated in liposomes.
    Maitani Y, Katayama S, Kawano K, Hayama A, Toma K.
    Biol Pharm Bull; 2008 May 01; 31(5):990-3. PubMed ID: 18451532
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.